EUCTR2020-006003-42-DK进行中（未招募）1 期
ational Cohort Study of Effectiveness and Safety of SARS-CoV-2/Covid-19 vaccines (ENFORCE) - ENFORCE
CHIP - Rigshospitalet - University of Copenhagen0 个研究点目标入组 10,000 人开始时间: 2020年12月21日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 10,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1.Written informed consent obtained before any trial related procedures are performed
- •2.Male or female eligible for SARS-CoV-2 immunization (as defined by SST in the national vaccination plan)
- •3.The subject must be willing and able to comply with trial protocol (re-visits and biological samples)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 5000
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 5000
排除标准
- •1.Male and female under the age of 18
- •2.Any subgroup of individuals for which the vaccines are contra-indicated
- •3.Previous SARS-CoV-2 vaccination
研究者
相似试验
招募中
Unknown
Cohort Study to Evaluate the Efficacy and Safety of Postoperative Adjuvant Therapy in HER2 Positive Elderly Breast Cancer Patients with Muti-gene assayHER2 Positive Elderly Breast Cancer PatientsJPRN-UMIN000051581Public Health Research Foundation266
已完成
3 期
Cohort Study to Evaluate the Efficacy and Safety of Postoperative Adjuvant Therapy in HER2 Positive Elderly Breast Cancer PatientsHER2 positive primary breast cancer in elderlyJPRN-UMIN000028476RESPECT executive committee300
招募中
4 期
Effectiveness and safety of COVID-19 vaccinesJPRN-jRCT1051200143Kayeka Hiroshi1,500
招募中
不适用
A prospective cohort study of efficacy and safety by methods of the procedure of transcatheter arterial chemoembolization with hepatocellular carcinoma.hepatocellular carcinomaJPRN-UMIN000021461Chiba University Hospital225
已完成
不适用
Prospective cohort study for safety and efficacy of low dose nab-paclitaxelBreast cancerJPRN-UMIN000013275Department of Surgical Oncology Osaka City University Graduate School of Medicine20